Transformation from Novartis to GSK Consumer Healthcare to Haleon
For over 10 years, we have been assisting the Nyon-Prangins team at the Haleon campus in Switzerland with their internal communications. This campus employs around 1,100 staff of more than 50 nationalities who are responsible for developing, manufacturing and marketing high-quality healthcare products, such as Voltaren, Panadol and Otrivin.
Together, we evolved from Novartis to GSK Consumer Healthcare in 2015 and since 2022, this division has been operating independently under the name Haleon.